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Abstract
We recently demonstrated that limb remote preconditioning (LRP) protects against focal ischemia measured 2 days post-
stroke. Here, we studied whether LRP provides long-term protection and improves neurological function. We also
investigated whether LRP transmits its protective signaling via the afferent nerve pathways from the preconditioned limb to
the ischemic brain and whether inflammatory factors are involved in LRP, including the novel galectin-9/Tim-3 inflammatory
cell signaling pathway, which induces cell death in lymphocytes. LRP in the left hind femoral artery was performed
immediately before stroke. LRP reduced brain injury size both at 2 days and 60 days post-stroke and improved behavioral
outcomes for up to 2 months. The sensory nerve inhibitors capsaicin and hexamethonium, a ganglion blocker, abolished the
protective effects of LRP. In addition, LRP inhibited edema formation and blood-brain barrier (BBB) permeability measured 2
days post-stroke. Western blot and immunostaining analysis showed that LRP inhibited protein expression of both galectin-
9 and T-cell immunoglobulin domain and mucin domain 3 (Tim-3), which were increased after stroke. In addition, LRP
decreased iNOS and nitrotyrosine protein expression after stroke. In conclusion, LRP executes long-term protective effects
against stroke and may block brain injury by inhibiting activities of the galectin-9/Tim-3 pathway, iNOS, and nitrotyrosine.
Citation: Wei D, Ren C, Chen X, Zhao H (2012) The Chronic Protective Effects of Limb Remote Preconditioning and the Underlying Mechanisms Involved in
Inflammatory Factors in Rat Stroke. PLoS ONE 7(2): e30892. doi:10.1371/journal.pone.0030892
Editor: Jean-Claude Baron, University of Cambridge, United Kingdom of America
Received September 26, 2011; Accepted December 23, 2011; Published February 8, 2012
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This study was supported by NINDS grants 1R21NS057750-01A2 (HZ) and 1R01NS 064136-01 (HZ). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hzhao@stanford.edu
. These authors contributed equally to this work.
Introduction
Remote preconditioning refers to a brief or repeated brief
ischemia performed in a distal organ to protect against a
prolonged ischemia in another vital organ. Limb remote
preconditioning (LRP), which is performed in hind limbs, is one
of the most frequent remote preconditioning methods used to
protect against heart and brain ischemia. LRP was reported to
reduce hippocampal neuronal injury in global ischemia in rats [1],
and this has been confirmed by several independent research
groups using cardiac arrest or global ischemia models [2–4]. In
addition, we recently showed that LRP performed immediately,
12 hours and 2 days before stroke reduced infarct size measured 2
days post focal cerebral ischemia [5]. In terms of clinical
applicability for stroke treatment, remote preconditioning may
have advantages over conventional ischemic preconditioning
because instead of the higher risk treatment directly to the brain,
remote preconditioning is performed in a non-vital organ [6–8]. In
fact, remote preconditioning has moved into clinical trials in
carotid endarterectomy [9], where preconditioning with 10 min-
utes of lower limb ischemia-reperfusion tended to improve
neurological deficits as measured by saccadic latency, although
no significant difference was reached. To facilitate the translation
of remote preconditioning to stroke patients, more studies are
needed to understand its underlying protective mechanisms.
Previously we reported on the short-term protection of LRP on
infarct size [5]. Here we further address whether LRP has long-
term protective effects. Because some neuroprotectants only offer
transient protection against brain injury [10,11], we measured the
size of brain injury and performed behavioral testing for up to 2
months. Edema formation and blood brain-barrier (BBB)
permeability are critical to brain injury; therefore, we also
measured the effects of LRP on these factors. In addition, we
studied how limb ischemia transfers protective signaling from the
limb to the brain. Since the afferent nerve pathways have been
shown to contribute to remote preconditioning in myocardial
ischemia [12–14], we tested whether these pathways are also
involved in the protective effects of LRP in stroke.
Many cell signaling pathways are involved in neuronal death
induced by stroke. Nevertheless, limb ischemia may first affect
blood circulation and the function of various blood cells, including
T cells, macrophages and neutrophiles, which are closely
associated with brain inflammation [15–17]. Thus, we assumed
that LRP may inhibit inflammation in the brain, and chose to
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generation of inflammation and free radicals, including galectin-9
and T-cell immunoglobulin domain and mucin domain 3 (Tim-3),
inducible nitric oxide synthase (iNOS), and nitrotyrosine.
Tim-3 regulates the inflammatory response [18]. When Tim-3
is expressed on CD4
+T-helper 1 (TH1) cells, it is triggered and
activated by its ligand galectin-9, which causes calcium influx and
cell aggregation that induces TH1 cell death. Therefore, it inhibits
the inflammatory response by eliminating TH1 cells [19]. In
addition, Tim-3 is also expressed on nerve cells in the brain [20],
but its role in the brain is not known.
This study used one of our previously established LRP model in
rats [5] where LRP was performed immediately before stroke
onset. We used a battery of behavioral tests to examine
neurological deficiency for up to 2 months and used Western blot
and immunostaining to investigate protein levels of the inflam-
matory and oxidative factors mentioned above.
Results
LRP offered long-term protection and attenuated
neurological deficiency
LRP performed immediately before ischemia onset reduced
infarct size measured 2 days post-stroke (Fig. 1B) as we previously
reported [5]. In this study, we further detected long-term
protective effects of LRP in both brain injury and behavioral
Figure 1. LRP reduced brain injury after focal ischemia. A. Diagram of the LRP protocol. In the LRP group, 3 cycles of 15 min occlusion/
reperfusion of the left femoral artery was induced before stroke onset. In the control group, 90 min of isoflurane was applied before ischemia, as a
vehicle control for LRP. B. Top: Representative brain sections of TTC staining from rats receiving focal ischemia with and without LRP. Bottom: Bar
graph showing the quantitation of infarct sizes in the ischemic cortex measured at each level and normalized to the non-ischemic contralateral
cortex, and expressed as percentage. C. Top: Representative staining of cresyl/violet from rat brains 60 d post-stroke. The lost and damaged tissues
are traced with dashed lines. Bottom: Bar graph showing the average value from 4 levels of brain sections. Control, control ischemia. LRP, limb remote
preconditioning. N=6–7/group. **, ***, P,0.01, 0.001, respectively, vs. control.
doi:10.1371/journal.pone.0030892.g001
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injury size by 40% at 2 months after stroke (Fig. 1C). Three
standard behavioral tests were performed to evaluate the
protective effect of LRP on neurological function (Fig. 2). In the
vibrissae test, placing of the forelimb contralateral to the injury
was disrupted from 1 to 60 days after stroke in control ischemic
rats; LRP did not prevent such disruption at 1day but attenuated it
thereafter until day 60 (Fig. 2A). Scores for the postural reflex test
were increased at 1 and 2 days, remained high until 14 days, then
gradually decreased to normal levels in control rats; the scores
were attenuated by LRP from 2 to 14 days (Fig. 2B). Lastly, in the
home cage test, control ischemic rats showed a bias in favor of the
ipsilateral forelimb from 1 to 7 days after stroke; LRP attenuated
this bias at 2 and 7 days (Fig. 2C).
LRP reduced BBB leakage and brain edema
BBB permeability at 2 days post-stroke was measured by Evans
blue. The level of Evans blue was robustly increased at 48 hours
after stroke in the ischemic penumbra (Fig. 3A), but much higher
levels were detected in the core than in the penumbra. LRP
blocked BBB leakage in the penumbra at 48 hours but had no
effect in the core (Fig. 3A).
Brain edema was also detected 2 days after stroke by the wet-dry
method. More water content was detected in rats receiving stroke
with and without LRP than in sham rats without ischemia.
However, LRP significantly reduced water content compared to
control ischemic rats (Fig. 3B), suggesting that LRP attenuated
stroke-induced edema.
Blocking the nerve pathways inhibited the protective
effect of LRP
We examined whether afferent nerve pathways transfer the
protective signaling from the preconditioned limb to the brain.
First, both systemic injection and local application of capsaicin to
the femoral nerve increased the infarct size in rats receiving LRP
(Fig. 4A), but systemic injection of capsaicin did not increase
infarct size in rats receiving control ischemia. These results suggest
that sensitive nerve activity contributes to the protective effects of
LRP but had no effect on ischemia alone. Second, we injected the
ganglion blocker, hexamethonium, into rats. Again, hexametho-
nium injection did not enlarge infarct size in rats receiving control
ischemia, but it increased infarct size in rats receiving stroke with
LRP (Fig. 4B), suggesting that hexamethonium abolished the
protective effects of LRP.
LRP blocked upregulation of galectin-9/Tim-3 expression
induced by stroke
We then investigated whether the novel galectin-9/Tim-3 cell
signaling pathway, which causes TH1 cell death in the immune
system, is involved in neuronal death after stroke. Results by
Western blot suggest that the expression of galectin-9 was
increased as early as 5 hours after stroke, and lasted at least to
24 hours (Fig. 5). LRP unexpectedly increased the expression of
galectin-9 at 1 hour but blocked it at 24 hours. The expression of
galectin-9 in control ischemia and the effect of LRP were
confirmed by immunofluorescent staining (Fig. 5). Tim-3 expres-
sion, which is downstream of galectin-9, was increased only at
24 hours after stroke, and this increase was inhibited by LRP
(Fig. 6).
LRP blocked protein expression of iNOS and nitrotyrosine
We also examined some critical molecules related to free radical
production and inflammation, including iNOS and nitrotyrosine;
nitrotyrosine is a product derived from iNOS activity. Western
blot showed that iNOS protein levels were increased as early as
1 hour and lasted up to 24 hours, and its expression was blocked
by LRP (Fig. 7A–D). Immunostaining also showed highly
increased nitrotyrosine levels 24 hours post-stroke and LRP
attenuated its expression (Fig. 7E).
Discussion
This study contains several novel findings. First, we demon-
strated that LRP offers long-term protective effects against focal
ischemia in rats, as evidenced by the reduced size of brain injury
measured 2 months post-stroke and improved performance during
behavioral tests. Second, we provided more data to support the
involvement of afferent nerve pathways in transferring protective
signaling from the ischemic limb to the ischemic brain, as two
afferent sensory nerve inhibitors, capsaicin and hexamethonium,
blocked the protective effects of LRP. A recent study also showed
that hexamethonium blocked the protective effects of limb
preconditioning [4]. Third, we further showed that the galectin-
9/Tim-3 pathway is involved in neuronal injury after stroke, and
LRP blocked its overexpression. Last, we found that LRP inhibited
edema formation, BBB permeability, and iNOS and nitrotyrosine
production.
We offered solid evidence that LRP has chronic protective
effects against stroke based on the measurement of brain injury
and behavioral tests up to 2 months post-stroke. It is important to
confirm this effect for clinical translation because several
neuroprotectants, such as certain types of post-ischemic hypother-
mia [21] and rapid ischemic preconditioning [22], only transiently
reduced infarct size. More recently, we also found that limb
ischemic postconditioning, which was performed after reperfusion,
reduced infarct size measured at 2 days but not at 1 month after
stroke [11]. Nevertheless, in the current study, LRP not only
reduced the loss of brain tissue measured 2 months after stroke,
but also attenuated deficits in behavioral tests performed from 1
day to 2 months post-stroke, suggesting a long-term protective
effect of LRP against stroke.
The afferent nerve systems appear to transfer the protective
signaling from the preconditioned limb to the brain. Afferent
neurons receive and transmit information from the peripheral
organs or tissues to the central nervous system and contribute to
the organism’s ability to maintain homeostasis. In the case of
ischemic limb preconditioning, repetitive ischemia and reperfusion
resulted in the release of substances, such as adenosine and
bradykinin [23] [24], which stimulate the afferent neurons that
may transmit protective signaling to the brain. The afferent nerve
system consists of peripheral fibers and endings along with
neuronal bodies located in the spinal sensory ganglia that ascend
to the brain stem and specific nuclei in the thalamus which, in
turn, send information to the cerebral cortex. It is known that
information from one side of the body can be sent to the opposite
cortex in the primary sensory cortex and both sides of the
secondary cortex [25]. In this study, both limb and brain ischemia
were performed in the left side. We showed that capsaicin, which
causes desensitization via its action on the peripheral fibers and
endings of the afferent neurons [13,14], blocked the protective
effects of LPR. In addition, we found that hexamethonium, which
inhibits the afferent neurons by blocking the ganglion
[12,24,26,27], also enlarged infarct size in animals treated with
LRP. These two experiments suggest that protective information
from the left limb can be sent to the same side of the brain cortex
via the afferent neuronal pathways. Nevertheless, additional
experiments should be conducted to more clearly demonstrate
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innervation.
We showed that the galectin-9/Tim-3 pathway is involved in
neuronal injury induced by cerebral ischemia and that LRP
attenuated the expression of galectin-9 and Tim-3 in the ischemic
brain, suggesting that the inhibition of this pathway may
contribute to the protective effects of LRP. This is a novel
pathway involved in immune modulation and inflammatory
response [28–30]. It was originally indentified in T cells and
subsequently in macrophages and dendritic cells. A recent study in
mice showed increased mRNA levels of Tim-3 in the brain 3 days
after stroke [31], but the cell types on which it was induced was not
reported. In this study, we showed that protein expression of
galectin-9 was increased as early as 5 hours after stroke, but Tim-3
levels were only increased 24 hours later. It seems that Tim-3
overexpression was induced after galectin-9, which is consistent
with previous studies that galectin-9 is a trigger for Tim-3
activities. Since the major role of the galectin-9/Tim-3 pathway is
to induce cell death, its induction in ischemic neurons might be
attributable to ischemic neuronal injury. Nevertheless, galectin-9
was induced at 1 hour after stroke in the LRP group, which is
earlier than that in the control group. Whether this early induction
is beneficial or detrimental is not known. Despite this, we found
that LRP inhibited increases in both galectin-9 and Tim-3
expression at 24 hours post-stroke, suggesting that inhibition of
the galectin-9/Tim-3 pathway may be a target for stroke therapy.
Last, we found that LRP blocked increases in iNOS and
nitrotyrosine expression. The induction of iNOS is critical for
neuronal injury and inflammation under oxidative stress, including
stroke [32–34]. In our study, iNOS protein expression was
immediately upregulated after focal ischemia from 1 to 24 hours,
and these increases were robustly blocked by LRP. Nitrotyrosine is
a product of tyrosine nitration generated by ROS, a maker of NO-
dependent products derived from iNOS, and its expression
indicates cell damage and inflammation [35–37]. Thus, we also
measured the expression of nitrotyrosine, which was also inhibited
by LRP, corroborating its effects on iNOS.
In conclusion, we found that LRP provides long-term protection
against focal cerebral ischemia, and it may transmit protective
signaling through afferent nerve pathways. The inhibitive effects of
LRP on edema formation, BBB permeability, the galectin-9/Tim-
3 pathway, and ROS activities, may contribute to its protective
effects against stroke.
Materials and Methods
Focal cerebral ischemia and remote preconditioning
Experimental protocols were approved by the Stanford
University Administrative Panel on Laboratory Animal Care
(Protocol #: APLAC 12642), and experiments were conducted in
accordance with the guidelines of Animal Use and Care of the
National Institutes of Health and Stanford University. Male
Sprague-Dawley rats (250–350 g) were used. Anesthesia was
induced by 5% isoflurane and maintained with 2–3% isoflurane
during surgery and early reperfusion. Core body temperature was
monitored with a rectal probe and maintained at 37uC during the
Figure 2. LRP attenuated behavioral deficits for up to 2 months
post-ischemia. Three standard tests were performed. A. Vibrissae-
elicited forelimb placement test. All sham rats showed normal forelimb
placing. Control ischemic rats exhibited unsuccessful placing of the
contralateral forelimb (right) after stroke. The reflex was tested 10 times
on each side per trial, and 2 trials occurred per test session. The
percentage of vibrissa stimulations in which a paw placement occurred
was calculated. LRP attenuated the overall deficit from 2 to 60 d after
stroke. B. Postural reflex test. Scores were increased in control rats at 1,
2, 7, 10, and 21 d after stroke; LRP reduced scores at 10 and 14 d after
stroke compared with control stroke. C. Home cage forelimb use test.
The number of times the animal used its forelimbs to brace itself
against the wall of the cage was counted, with separate counting for
the ipsilateral, contralateral, or both forelimbs until 20 contacts were
reached. The percentage of times out of 20 that the ipsilateral forelimb
(left) was used was computed. The ratio of left-limb-use was increased
at 1, 2 and 7 d compared to control ischemia; LRP blocked this increase
at 2 d. *, ** vs. control ischemia, and #, ##, vs. sham, P,0.05, 0.01 at
the corresponding time points, respectively. N=6–8/group.
doi:10.1371/journal.pone.0030892.g002
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remote preconditioning are shown in Fig. 1. Animals in both the
control ischemic and remote preconditioning groups received
90 min of anesthesia before stroke onset. Focal ischemia was
induced as described previously [5,8,38–41]. The bilateral
common carotid arteries (CCAs) were separated and occluded
by aneurysms clips for 30 minutes, and the left distal middle
cerebral artery (MCA) was cauterized above the rhinal fissure. To
induce remote preconditioning, the left femoral artery was
separated below the left groin ligament, occluded for 15 minutes
and released for another 15 minutes, and repeated for 3 cycles.
Stroke was performed immediately after remote preconditioning.
Infarct size measurement
Rats were re-anesthetized with an overdose of isoflurane at the
desired time after stroke, perfused intracardially with 100 ml of
cold 10 mM sodium phosphate buffered saline (PBS; pH 7.4). The
rats were then decapitated and the brains were rapidly removed
and sectioned coronally at 2 mm intervals. Four sections were
used for infarct measurement. As defined above, slices from rat
brains 2 days post-stroke were incubated for 20 minutes in a 2%
solution of 2,3,7-triphenyltetrazolium chloride (TTC) at room
temperature and fixed by immersion in 4% paraformaldehyde
(PFA) solution. Using a computerized image analysis system (NIH
image, version 1.61), the area of infarction of each section was
measured. Infarct size of the ischemic cortex was normalized to
the non-ischemic cortex and expressed as a percentage, and an
average value from the 4 slices was presented according to the
formula: [(area of the cortex in the non-ischemic hemisphere –
area of the normal cortex in the ischemic hemisphere)/area of the
non-ischemic cortex]6100% [8,38,39].
Rat brains for those surviving 2 months were also sectioned into
4 blocks and fixed in 4% PFA/20% sucrose for 24 hours, frozen,
sectioned into 30 mm slices on cryostat, and stained with cresyl/
violet. The area of injured and lost ischemic cortex was traced
under a microscope, scanned, measured and calculated as a
percentage of the area of the intact, non-ischemic cortex according
to the following formula: [(area of non-ischemic cortex - area of
remaining ischemic cortex)/area of non-ischemic cortex]6100
[39].
Behavior testing
Rats were randomly assigned into 3 groups for behavior tests:
the sham surgery group received sham surgery without ischemia
and preconditioning; the control ischemic group received stroke
but without LRP; and the preconditioning group received both
ischemia and LRP. We used a battery of standard behavior tests to
quantify motor asymmetry caused by a unilateral cortical stroke as
described in our previous studies [39,41,42]. All behavior tests
were performed by a person who was blind to the experimental
conditions. Most tests were performed before dMCA occlusion
and then on days 1, 2, 3, 7, 10, 14, 21, 30, 37, 44 and 60 after
dMCA occlusion.
The vibrissae-elicited forelimb placement test, which was used
to detect forelimb placing against the edge of a table, was induced
by gently brushing the rats’ vibrissae on each side; the reflex was
tested 10 times on each side per trial, and two trials occurred per
test session. The percentage of vibrissae stimulations in which a
paw placement occurred was calculated.
For the postural reflex test, the rat was placed on a table and the
tail was held by one hand while the other hand gently pushed the
animal’s shoulder, moving it laterally ,20 cm. The use of the
forelimbs to resist the lateral movement was scored either 0, 1 or 2,
Figure 3. LRP attenuated edema induced by stroke. A. Diagram
of the dissected regions of the ischemic penumbra and core for BBB
leakage measurement. The penumbra (I) is defined as the ischemic
region spared by LRP, while the core (II) is the ischemic part that
developed into the infarction. The same regions were also dissected for
Western blotting. B. LRP inhibited BBB leakage. Evans blue was injected
2 h before the rat was euthanized. The ischemic penumbra and core, as
well as the corresponding non-ischemic hemisphere were dissected for
Evans blue detection. LRP reduced BBB leakage at 48 h after stroke in
the penumbra but not in the core (n=6/group). * vs. control ischemia,
P,0.05. C. LRP mitigated edema after stroke. The ischemic and non-
ischemic hemispheres from each rat brain were separated, weighed for
wet weight, baked at 9062uC for 1 wk, and weighed again for dry
weight. Water contained in the brain tissues was calculated and is
presented in the bar graph (n=6–7/group). *** vs. contralateral
hemisphere, P,0.001; ### vs. sham and control ischemia, P,0.001.
doi:10.1371/journal.pone.0030892.g003
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indicative of severe brain injury as defined in our previous study.
The home cage limb use test was performed after completing
the other behavior tests. The animal was returned to its home
cage, and the number of times the rat used its forelimbs to brace
itself against the wall was counted; with separate counting for the
ipsilateral, contralateral, or both forelimbs, until 20 such contacts
were reached. The number of times out of 20 that the ipsilateral
forelimb contacted was computed as a percentage using this
formula: (ipsilateral+(both/2))/206100%.
Evaluation of BBB integrity
To examine whether LRP prevents BBB leakage, BBB integrity
48 hours post-stroke was studied using Evans blue [42]. Evans
blue (4%, 2 ml/kg) was injected intravenously (i.v.) into ischemic
rats, and the rats were perfused with heparinized saline solution
2 hours later. The brains were harvested, and the ischemic core
and penumbra in the ipsilateral hemisphere and the contralateral
cortex were dissected, weighed, homogenized and incubated in
500 ml formamide at 54uC for 2 hours. The solution was
centrifuged at 12,000 g for 15 minutes, the supernatant was
removed, and Evans blue was measured using spectrophotometry
(absorbance at 620 nm) (Spectro Max 340, Molecular Devices,
Sunnyvale, CA, USA). The amount of Evans blue was computed
based on external standards in the same solvent (1–20 mg/ml) and
expressed as per gram of tissue.
Edema measurement
To examine the effect of LRP on edema, rats were randomly
assigned to 3 groups: sham surgery rats without ischemia,
ischemic rats without LRP and ischemic rats with LRP. Rats
that survived 48 hours after stroke were euthanized for edema
measurements using the wet-dry weight method [42]. Briefly,
after euthanization, the ischemic and non-ischemic hemispheres
from each block were separated, weighed for wet weight, baked at
9062uC for 1 week, and weighed again for dry weight. Water
content in brain tissues was calculated as: [12(dry weight/wet
weight)]6100%. The mean values from the left 6 blocks of
ischemic hemisphere and from the right 6 blocks of non-ischemic
hemisphere represent the water content in the ischemic and non-
ischemic hemisphere, respectively.
Drug injection
We used the afferent nerve blocker, capsaicin, to test whether
the nerve pathway is involved in transferring protective signaling
from the limb to the brain during remote preconditioning.
Capsaicin was dissolved in 10% ethanol, 10% Tween-80 and
80% saline to a final concentration of 4 mg/ml. The method for
capsaicin injection was modified from previous studies [13,43].
Figure 4. Blocking nerve pathways enlarged infarct size in rats
receiving LRP. A. Systemic injection of capsaicin enlarged
infarction in rats receiving LRP. Capsaicin was subcutaneously
injected into rats for 4 consecutive days. LRP and focal ischemia were
conducted 2 wks after capsaicin injection, and infarct sizes were
measured 2 d after stroke. The bar graphs represent the mean values of
infarct size in 4 groups: 1) ischemia, control ischemia; 2) LRP, animals
receiving LRP plus ischemia; 3) capsaicin+LRP, animals receiving
capsaicin injection, LRP and ischemia; 4) capsaicin+ischemia, animals
receiving capsaicin and control ischemia. B. Local application of
capsaicin onto the thigh nerve in the hind limb abolished the
protective effects of LRP. The nerve was soaked with a capsaicin
solution for 30 min. Four days later LRP and focal ischemia were
conducted. The bar graphs show average infarct sizes. C. The ganglion
blocker hexamethonium blocked the protective effects of LRP.
Hexamethonium was intravenously injected into rats 30 min before
LRP induction. Infarct sizes were measured at 2 days after stroke. The
bar graphs show the average values of infarct size of 4 groups. 1)
Ischemia, control ischemia without LRP; 2) LRP, animals receiving
ischemia and LRP; 3) Hex+LRP, animals receiving hexamethonium, LRP
and ischemia; 4) Hex+ischemia, animals receiving hexamethonium and
ischemia without LRP. N=7/group. *, *** vs. ischemia, P,0.05, 0.001,
respectively. #, ##, vs. LRP.
doi:10.1371/journal.pone.0030892.g004
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rats under isoflurane anesthesia were subcutaneously injected with
capsaicin or vehicle for 4 consecutive days (n=6/group): day 1,
12.5 mg/kg; day 2, 12.5 mg/kg, twice at 12 hour intervals; day 3,
25 mg/kg twice at 12 hour intervals; day 4, 25 mg/kg. To check
the effectiveness of the capsaicin denervation, one drop of a
0.1 mg/ml solution of capsaicin was placed onto the eye of each
rat and their protective movements were observed. All animals
pretreated with capsaicin showed no wiping movements, thus
confirming functional denervation of the capsaicin-sensitive
nerves. Focal ischemia and LRP were performed 2 weeks after
the last capsaicin injection. The operator performing the surgery
was blind to the rats’ condition. All rats receiving drug and vehicle
treatments were sacrificed 2 days after stroke for infarction
measurement.
To examine if local application of capsaicin also affects LRP,
capsaicin was applied to the left thigh nerve of rats. In brief, rats
were anesthetized and the left thigh nerve was exposed.
Approximately 1-cm-long segments of left nerve were isolated
with Parafilm and small pieces of gelfoam moistened with a
capsaicin solution (1%, 100 ml) were wrapped around the nerve for
30 min. The capsaicin-exposed area was then flushed with saline
and the wound was closed. In some control animals, the left nerve
was similarly treated with saline. LRP and focal ischemia were
performed 4 days later.
We further used the ganglionic blocker, hexamethonium, which
blocks the afferent nerve pathways, to test whether the afferent
nerves transfer protective signaling from the preconditioned limb
to the brain. Hexamethonium was dissolved in saline and injected
(i.v) (20 mg/kg) into rats 30 minutes before LRP. Thereafter,
stroke was induced and animals were euthanized 2 days later for
infarct size measurement.
Immunofluorescence staining and confocal microscopy
[39]
Rats were transcardially perfused with ice-cold PBS (pH 7.4)
and 4% PFA solution. Brains were post-fixed in 4% PFA solution
and cytoprotected in 20% sucrose at 4uC overnight. We stained
cryostat sections (40 mm) with antibodies against Tim-3 (1:100;
Santa Cruz Biotechnology; sc-30326), Galectin-9 (1:50; Santa
Cruz Biotechnology; sc-19292), and nitrotyrosine (1:50; Millipore
(Chemcon); 92590). Neurons were stained with microtubule-
Figure 5. LRP inhibited galectin-9 expression 24 h after stroke. A and B. Representative protein bands of galectin-9 from Western blots for
control ischemia and LRP with ischemia, respectively. C and D. The bar graphs show protein band quantitation results corresponding to A and B,
respectively. Brain tissue from ischemic penumbras were dissected for Western blotting, as indicated in Fig. 3A. *, vs. sham, P,0.05, ***, vs. sham,
P,0.001. n=6/group. E. Results from confocal microscopy indicate that galectin-9 was increased in the ischemic penumbra 24 h after stroke, and
such expression was inhibited by LRP. Scale bar, 50 mM.
doi:10.1371/journal.pone.0030892.g005
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staining of Tim-3 and MAP-2 was performed consecutively with
their primary and secondary antibodies, respectively. Fluorescent-
stained sections were analyzed by confocal microscopy.
Western blot
Rats were randomly assigned into different groups, euthanized
at 1, 5, 24, and 48 hours (n=6/group), and rat brains were
harvested for immunostaining and western blot at different time
points as described previously [39,41]. Samples were lysed with
RIPA buffer (10 mM TRIS, 140 mM Nacl, 1% Triton, 1% Na-
deoxycholate, 0.1% SDS, 0.5 mM phenylmethylsulfonyl fluoride
(PMSF) and supplemented with cocktail inhibitors; Roche).
Extracts were homogenized and insoluble debris removed by
centrifugation at 6000 g for 10 minutes at 4uC. Protein concen-
tration in the resulting supernatants was calculated using a Pierce
protein assay kit according to the manufacturer’s instructions
(Pierce, IL). Equal amounts of protein samples (13 ml) were loaded,
separated using 4–15% SDS-polyacrylamide gel (Bio-Rad Labo-
ratories, Hercules, CA) electrophoresis and then transferred to
Trans-Blot nitrocellulose membrane (BioRad, CA). Membranes
were scanned using Typhoon trio (GE Healthcare). We used
Figure 6. Tim-3 expression was increased after stroke and inhibited by LRP. A and B. Western blots showing representative protein bands
of Tim-3 and b-actin in the ischemic penumbra for rats receiving control ischemia alone and ischemia plus LRP, respectively. C. Bar graphs indicating
that Tim-3 was slightly increased as early as 1 h and peaked at 24 h after stroke. D. This was inhibited by LRP. ***, vs. sham, P,0.001. n=6/group. E.
The results were further confirmed using immunofluorescent confocal microscopy in control ischemia and LRP 24 h after stroke. An ischemic brain
was collected from a surviving rat 24 h after stroke, fixed for 24 h with 4% PFA, stained, and examined with confocal microscopy. F. Double staining
of MAP-2 and Tim-3 suggests that Tim-3 was expressed in neurons. Scale bar, 50 mM.
doi:10.1371/journal.pone.0030892.g006
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ogy; sc-30326), Nitrotyrosine (1:500; Millipore (Chemcon); 92590),
iNOS (1:10000; BD Biosciences; 610431), and b-actin (1:10000;
Sigma; A3854).
Statistical Analysis
One-way analysis of variance (ANOVA) was used to compare
each group on infarct size followed by Fisher’s least square
difference post hoc test when there were more than 3 groups; t-test
was used to compare infarct size when only 2 groups were studied.
For behavioral tests, one-way repeated measures ANOVA was
used to compare tests at different time points in the same group,
and two-way ANOVA was used to compare between LRP and
control ischemia, followed by the Student–Newman–Keuls test.
Tests were considered significant at P-values,0.05. Data are
presented as mean 6 s.e.m.
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